St James’s Place shares gain on 2027 profit outlook

St James’s Place shares gain on 2027 profit outlook

July 6, 2026

LONDON, July 6, 2026, 18:02 BST

  • St. James’s Place gained 2.23% to £13.32. The FTSE 100 slipped 0.26%.
  • The stock was still down 15.46% from its 52-week high of £15.76 set on Feb. 3.
  • The focus is turning to 2027 earnings instead of what the stock did Monday.

St. James’s Place Plc (LON:STJ) gained 2.23% to £13.32 on Monday, beating the FTSE 100 (INDEXFTSE:UKX), which slipped 0.26% to 10,651.77. Shares ended the session still down 15.46% from their 52-week high of £15.76 hit on Feb. 3.

The move came without a new company update. The latest notices on Investegate’s St James’s Place RNS feed were July 1 filings for admission to trading and total voting rights.

Hargreaves Lansdown quoted St. James’s Place at a 1,330p bid and a 1,331p offer after the London close, with the price up 29p from 1,303p. The group listed a market cap of £6.78 billion and volume of 4.39 million shares.

The sell-side profit track is more important here than just the first-day move, given that market value. St James’s Place’s Visible Alpha consensus has adjusted IFRS profit after tax dropping in 2026, then climbing again in 2027 and 2028. The table below holds Monday’s £6.78 billion market value steady.

YearAdjusted IFRS profit after tax consensusFUM consensusDividend per share consensusImplied market-cap/profit multiple
2026£405.9 mln£233.8 bln21.7p16.7x
2027£519.4 mln£250.5 bln29.6p13.1x
2028£638.7 mln£268.2 bln37.3p10.6x

This matters as the bull case for the stock now rests on asset growth and margin recovery. SJP’s consensus sees 2026 FUM at £233.8 billion, which is £16.9 billion higher than the £216.94 billion the firm posted at March-end.

St. James’s Place said in April it saw Q1 gross inflows hit £5.23 billion, with net inflows at £1.53 billion. The firm posted an annualised FUM retention rate of 95.3%. CEO Mark FitzPatrick described it as a “good first quarter,” but noted that FUM was impacted by market declines. St. James’s Place

Analyst price targets are still skewed to the upside, with a big spread. MarketBeat lists seven analysts calling it a “moderate buy,” with five buys, two holds, and an average 12-month target price at 1,689.71p. MarketBeat

Price-target measureMarketBeat figure
Average target1,689.71p
Highest target2,000p
Lowest target1,400p
Implied upside from 1,332p26.9%
Buy / hold / sell split5 / 2 / 0

St James’s Place has told investors it plans to return 70% of adjusted IFRS profit after tax to shareholders from 2026. That will come through dividends and buybacks, giving holders another number to track.

FitzPatrick told investors in February that the board is acting a year ahead of schedule on returns to shareholders. The group expects to announce a 6p interim dividend and launch an interim buyback after reporting its half-year 2026 numbers.

St James’s Place will publish half-year numbers and a second-quarter new business update on July 29, which is the next scheduled test.

Mateusz Brzeziński

Mateusz Brzeziński is a financial and technology journalist at Bez-kabli.pl, covering stocks, artificial intelligence, semiconductors and global market developments. He graduated from the Prague University of Economics and Business in the Czech Republic and previously worked in financial analysis before moving into business journalism. His reporting focuses on the companies, technologies and market trends shaping the global economy.

Stock Market Today

  • ASX small caps: WEL jumps 100%, GTI up 64%, MMR falls 25%; project news from AMU, ATH, BSR, PGD, ENP
    July 9, 2026, 9:09 PM EDT. ASX small caps traded sharply - Winchester Energy (WEL) soared 100% and Gratifii (GTI) added 64%, while Mec Resources (MMR) lost 25%. American Uranium (AMU) reported a confidence boost at its Wyoming uranium project, Alterity Therapeutics (ATH) said it got a A$3.98 million R&D tax incentive refund. Bison Resources (BSR) pointed to new gold signs in Nevada, Peregrine Gold (PGD) flagged fresh targets in Western Australia, and Entropy Neurodynamics (ENP) landed another patent for its neurodiagnostic tech. Investors kept watch as these companies continued exploration and innovation.